he added: �these findings show that despite the tireless work of doctors and nurses, it appears that some cancer patients are still enduring shockingly long waits to start treatment.
.
"their serious adverse incident process has been wholly inadequate and what we have heard this week is a damning indictment of the western trust.
.
.
.
.
.
cambridge's bluebird bio licenses delivery tech to novartis, gsk
.